Vimab Group AB (publ) (OM:VIMAB) entered into letter of intent to acquire B Göransson Produktion Ab for SEK 24 million on April 17, 2023. Share purchase agreement is scheduled on Q2 of 2023. The transaction is expected to complete on Q2 of 2023. Vimab Group AB (publ) (OM:VIMAB) entered into a share transfer agreement with the owner of B Göransson Produktion AB on June 29, 2023.

Vimab Group AB (publ) (OM:VIMAB) completed the acquisition of B Göransson Produktion Ab for SEK 24.2 million on June 29, 2023. The initial purchase price amounts to SEK 15.7 million, divided between a cash payment of SEK 5.2 million and shares in Vimab Group to a value of SEK 10.5 million. The additional purchase price amounts to a maximum of SEK 6.64 million, divided between a cash payment of SEK 3.84 million and shares in Vimab Group to a value of SEK 2.8 million, for the next twelve months after taking office. The acquisition is financed with own funds and bank loans. Vimab Group assesses that the acquisition will have a positive effect on Vimab Group's results during the business year 2023. Mangold Fondkommission AB acts as financial advisor and Wigge & Partners Advokat KB acts as legal advisor to Vimab Group in connection with the acquisition.